Neoadjuvant Oxaliplatin-Fluoropyrimidine Chemo Improves Colon Cancer Outcomes
Benefits include histopathologic downstaging, fewer incomplete resections, and better two-year disease control
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.